9.30
Arcturus Therapeutics Holdings Inc Aktie (ARCT) Neueste Nachrichten
What MACD signals say about Arcturus Therapeutics Holdings Inc.2025 Price Action Summary & Risk Controlled Daily Trade Plans - newser.com
Arcturus Therapeutics Holdings Inc. stock volume spike explainedTrade Exit Summary & Stepwise Trade Signal Implementation - newser.com
Is Arcturus Therapeutics Holdings Inc. stock cheap at current valuationJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
Published on: 2025-11-03 05:43:35 - newser.com
Can Arcturus Therapeutics Holdings Inc. stock beat market expectations this quarterEarnings Recap Report & Fast Gaining Stock Reports - newser.com
Advanced analytics toolkit walkthrough for Arcturus Therapeutics Holdings Inc.2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Real time scanner hits for Arcturus Therapeutics Holdings Inc. explainedJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com
What candlestick patterns are forming on Arcturus Therapeutics Holdings Inc.Market Growth Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Published on: 2025-11-02 01:11:00 - newser.com
How to forecast Arcturus Therapeutics Holdings Inc. trends using time seriesQuarterly Growth Report & Accurate Intraday Trading Signals - newser.com
Can momentum traders help lift Arcturus Therapeutics Holdings Inc.2025 Investor Takeaways & High Accuracy Swing Entry Alerts - newser.com
How Arcturus Therapeutics Holdings Inc. stock valuations compare to rivalsPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com
Published on: 2025-11-01 04:30:36 - newser.com
Is Arcturus Therapeutics Holdings Inc. stock attractive for income investorsJuly 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Is Arcturus Therapeutics Holdings Inc. stock ready for a breakoutTrade Volume Report & High Conviction Trade Alerts - newser.com
Sumitomo Mitsui Trust Group, Inc. Expands Stake in Arcturus Therapeutics Holdings Inc. - GuruFocus
High Growth Tech Stocks In US With Promising Potential - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arcturus Therapeutics Holdings Inc. (ARCT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-10-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arcturus Therapeutics Holdings Inc. (ARCT) and Encourages Investors to Learn More About the Investigation | NDAQ:ARCT | Press Release - Stockhouse
How currency fluctuations impact Arcturus Therapeutics Holdings Inc. stockPortfolio Update Report & Proven Capital Preservation Methods - newser.com
What technical models suggest about Arcturus Therapeutics Holdings Inc.’s comebackJuly 2025 EndofMonth & Weekly Momentum Stock Picks - newser.com
How Arcturus Therapeutics Holdings Inc. stock compares to market leaders2025 Momentum Check & Free Expert Verified Stock Movement Alerts - newser.com
Arcturus Therapeutics Holdings (ARCT) Price Target Decreased by 30.87% to 45.67 - MSN
Arcturus Therapeutics Holdings Inc. (ARCT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Arcturus Therapeutics Holdings Inc. (ARCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Published on: 2025-10-30 03:05:20 - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Arcturus Therapeutics Holdings Inc. (ARCT) And Encourages Investors to Connect - ACCESS Newswire
Arcturus Therapeutics Holdings Inc. $ARCT Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025 - BioSpace
Arcturus Therapeutics Holdings Inc (NQ: ARCT - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcturus Therapeutics Holdings Inc.ARCT - PR Newswire
Why Arcturus Therapeutics Holdings Inc. stock attracts high net worth investorsIPO Watch & Technical Analysis for Trade Confirmation - fcp.pa.gov.br
The Market Doesn't Like What It Sees From Arcturus Therapeutics Holdings Inc.'s (NASDAQ:ARCT) Revenues Yet As Shares Tumble 52% - simplywall.st
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):